Shine Investment Advisory Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$149K Sell
4,286
-901
-17% -$31.6K 0.05% 153
2020
Q2
$161K Hold
5,187
0.06% 137
2020
Q1
$161K Sell
5,187
-416
-7% -$14.2K 0.07% 124
2019
Q4
$208K Sell
5,603
-71
-1% -$2.53K 0.08% 121
2019
Q3
$193K Buy
5,674
+209
+4% +$7.6K 0.09% 113
2019
Q2
$225K Hold
5,465
0.1% 108
2019
Q1
$220K Hold
5,465
0.1% 110
2018
Q4
$226K Hold
5,465
0.11% 98
2018
Q3
$229K Sell
5,465
-30
-0.5% -$1.16K 0.12% 97
2018
Q2
$189K Sell
5,495
-329
-6% -$11.2K 0.1% 110
2018
Q1
$196K Sell
5,824
-218
-4% -$7.49K 0.1% 102
2017
Q4
$208K Sell
6,042
-2,197
-27% -$74.9K 0.1% 101
2017
Q3
$279K Buy
8,239
+5,041
+158% +$162K 0.15% 79
2017
Q2
$102K Buy
+3,198
New +$101K 0.05% 149

Other funds holding PFE

Shine Investment Advisory Services's PFE Position: Q3 2020 in Review

Shine Investment Advisory Services reduced its Pfizer (PFE) stake by 17% in Q3 2020, selling an estimated $31.6K and leaving 4,286 shares worth $149K. The position accounts for 0.05% of the portfolio, ranked #153.

Shine Investment Advisory Services first reported a position in PFE in Q2 2017 and has held it in 14 quarters since. The position peaked at $279K in Q3 2017. 2,509 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

  • Shine Investment Advisory Services held 4,286 shares of Pfizer worth $149K as of Q3 2020.
  • Shine Investment Advisory Services sold 901 Pfizer shares in Q3 2020, an estimated $31.6K.
  • Pfizer made up 0.05% of Shine Investment Advisory Services's portfolio in Q3 2020, its #153 holding.
  • Shine Investment Advisory Services first reported a position in Pfizer in Q2 2017 and has held it in 14 quarters since.
  • Shine Investment Advisory Services's Pfizer position peaked at $279K in Q3 2017.
  • 2,509 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.